{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:57:19Z","timestamp":1790776639212,"version":"4.1.0"},"reference-count":168,"publisher":"SAGE Publications","issue":"3_suppl","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2007,5]]},"abstract":"<jats:p>The oil derived from the seed of the Ricinus communis plant and its primary constituent, Ricinoleic Acid, along with certain of its salts and esters function primarily as skin-conditioning agents, emulsion stabilizers, and surfactants in cosmetics, although other functions are described. Ricinus Communis (Castor) Seed Oil is the naming convention for castor oil used in cosmetics. It is produced by cold pressing the seeds and subsequent clarification of the oil by heat. Castor oil does not contain ricin because ricin does not partition into the oil. Castor oil and Glyceryl Ricinoleate absorb ultraviolet (UV) light, with a maximum absorbance at 270 nm. Castor oil and Hydrogenated Castor Oil reportedly were used in 769 and 202 cosmetic products, respectively, in 2002; fewer uses were reported for the other ingredients in this group. The highest reported use concentration (81%) for castor oil is associated with lipstick. Castor oil is classified by Food and Drug Administration (FDA) as generally recognized as safe and effective for use as a stimulant laxative. The Joint Food and Agriculture Organization (FAO)\/World Health Organization (WHO) Expert Committee on Food Additives established an acceptable daily castor oil intake (for man) of 0 to 0.7 mg\/kg body weight. Castor oil is hydrolyzed in the small intestine by pancreatic enzymes, leading to the release of glycerol and Ricinoleic Acid, although 3,6-epoxyoctanedioic acid, 3,6-epoxydecanedioic acid, and 3,6-epoxydodecanedioic acid also appear to be metabolites. Castor oil and Ricinoleic Acid can enhance the transdermal penetration of other chemicals. Although chemically similar to prostaglandin E1 , Ricinoleic Acid did not have the same physiological properties. These ingredients are not acute toxicants, and a National Toxicology Program (NTP) subchronic oral toxicity study using castor oil at concentrations up to 10% in the diet of rats was not toxic. Other subchronic studies of castor oil produced similar findings. Undiluted castor oil produced minimal ocular toxicity in one study, but none in another. Undiluted castor oil was severely irritating to rabbit skin in one study, only slightly irritating in another, mildly irritating to guinea pig and rat skin, but not irritating to miniature swine skin. Ricinoleic Acid was nonirritating in mice and in one rabbit study, but produced welldefined erythema at abraded and intact skin sites in another rabbit study. Zinc Ricinoleate was not a sensitizer in guinea pigs. Neither castor oil nor Sodium Ricinoleate was genotoxic in bacterial or mammalian test systems. Ricinoleic Acid produced no neoplasms or hyperplasia in one mouse study and was not a tumor promoter in another mouse study, but did produce epidermal hyperplasia. Castor oil extract had a strong suppressive effect on S180 body tumors and ARS ascites cancer in male Kunming mice. No dose-related reproductive toxicity was found in mice fed up to 10% castor oil for 13 weeks. Female rats injected intramuscularly with castor oil on the first day after estrus had suppressed ovarian folliculogenesis and anti-implantation and abortive effects. Castor oil used as a vehicle control in rats receiving subcutaneous injections had no effect on spermatogenesis. A methanol extract of Ricinus communis var. minor seeds (ether-soluble fraction) produced anti-implantation, anticonceptive, and estrogenic activity in rats and mice. Clinically, castor oil has been used to stimulate labor. Castor oil is not a significant skin irritant, sensitizer, or photosensitizer in human clinical tests, but patients with occupational dermatoses may have a positive reaction to castor oil or Ricinoleic Acid. The instillation of a castor oil solution into the eyes of nine patients resulted in mild and transient discomfort and minor epithelial changes. In another study involving 100 patients, the instillation of castor oil produced corneal epithelial cell death and continuity breaks in the epithelium. Because castor oil contains Ricinoleic Acid as the primary fatty acid group, the Cosmetic Ingredient Review (CIR) Expert Panel considered the safety test data on the oil broadly applicable to this entire group of cosmetic ingredients. The available data demonstrate few toxic effects. Although animal studies indicate no significant irritant or sensitization potential, positive reactions to Ricinoleic Acid in selected populations with identified dermatoses did suggest that sensitization reactions may be higher in that population. Overall, however, the clinical experience suggests that sensitization reactions are seen infrequently. In the absence of inhalation toxicity data on these ingredients, the Panel determined that these ingredients can be used safely in aerosolized cosmetic products because the particle sizes produced are not respirable. Overall, the CIR Expert Panel concluded that these cosmetic ingredients are safe in the practices of use and concentrations as described in this safety assessment.<\/jats:p>","DOI":"10.1080\/10915810701663150","type":"journal-article","created":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T19:08:51Z","timestamp":1197572931000},"page":"31-77","source":"Crossref","is-referenced-by-count":69,"title":["Final Report on the Safety Assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate1"],"prefix":"10.1177","volume":"26","member":"179","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02638537"},{"key":"atypb2","first-page":"557","volume":"120","year":"1981","journal-title":"Boll. Chim. Farm."},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(75)90046-1"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1984.tb00996.x"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1997.tb125050.x"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0231(20000415)14:7<608::AID-RCM918>3.0.CO;2-4"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2003.09.014"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1007\/BF02154739"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1007\/BF02531976"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/54.1.138"},{"key":"atypb11","unstructured":"Bower, D. 1999. Unpublished information on hair spray particle sizes provided at the September 9, 1999 CIR Expert Panel meeting."},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1966.21"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1983.tb04447.x"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600740117"},{"key":"atypb15","first-page":"59","volume":"45","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"atypb16","unstructured":"Budavari, S, ed. 1989.The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals, 11th ed., 290, 1307. Rahway, NJ: Merck & Co."},{"key":"atypb17","first-page":"4924","volume":"44","year":"1984","journal-title":"Cancer Res"},{"key":"atypb18","first-page":"1771","volume":"48","year":"1988","journal-title":"Cancer Res"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1951.13"},{"key":"atypb20","first-page":"43","volume":"21","year":"1952","journal-title":"J Invest Dermatol"},{"key":"atypb21","unstructured":"Campbell & Co. 2002. Castor oil & castor oil derivatives. Product data-castor waxes. http:\/\/www.campbelluv.com\/castor.html [accessed September 2004]."},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1986.tb03097.x"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb17113.x"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(46)92032-6"},{"key":"atypb25","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1963.tb12791.x"},{"key":"atypb26","unstructured":"Committee of Revision of the United States Pharmacopeial Convention. 2004a. The\n                      United States Pharmacopoeia\n                      , 27th ed., 348. Rockville, MD: United States Pharmacopeial Convention."},{"key":"atypb27","unstructured":"Committee of Revision of the United States Pharmacopeial Convention. 2004b. The National Formulary, 22nd ed., 2844. Rockville, MD: United States Phar-macopeial Convention."},{"key":"atypb28","unstructured":"Cornell University. 2001. Castor Oil. http:\/\/www.ansci.cornell.edu\/ plants\/castorbean.html [accessed October 2003]."},{"key":"atypb29","unstructured":"Cosmetic, Toiletry, and Fragrance Association (CTFA). 2004. Use concentration data from industry survey. Unpublished data submitted by CTFA, May 2004. 3 pages."},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701130"},{"key":"atypb31","doi-asserted-by":"publisher","DOI":"10.1016\/0091-2182(84)90166-6"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)33875-X"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199508000-00011"},{"key":"atypb34","unstructured":"De Groot, A. C., ed. 1994.Patch testing. Test concentrations and vehicles for 3700 Chemicals, 2nd ed., 11, 145. Amsterdam: Elsevier."},{"key":"atypb35","unstructured":"Degussa. 2001. Product data record. TEGODEO HY 77. Unpublished data submitted by CTFA, May 5, 2004. 2 pages."},{"key":"atypb36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1987.tb01468.x"},{"key":"atypb37","unstructured":"Drugstore.com, Inc. 2004. Rite Aid Castor oil, stimulant laxative U. S. P. Package details: Directions. http:\/\/www.drugstore.com [accessed December 2004]."},{"key":"atypb38","doi-asserted-by":"crossref","unstructured":"Elder, R. L. ed. 1988. Final reportonthe safety assessment of glyceryl ricinoleate.\n                      J. Am. Coll. Toxicol.\n                      7:721-739.","DOI":"10.3109\/10915818809078709"},{"key":"atypb39","first-page":"389","volume":"47","year":"1991","journal-title":"Cutis"},{"key":"atypb40","unstructured":"Food and Drug Administration (FDA). 1985. Laxative drug products for over-the-counter human use; Tentativefinal monograph.\n                      Federal Register\n                      50:2124-2158."},{"key":"atypb41","unstructured":"FDA. 1990. Wart remover drug products for over-the-counter human use. Final monograph.\n                      Federal Register\n                      55:33246-33256."},{"key":"atypb42","unstructured":"FDA. 2002. Frequency of use of cosmetic ingredients.\n                      FDA database.\n                      Washington, DC: FDA."},{"key":"atypb43","unstructured":"FDA. 2003a. OTC Drug Review Ingredient Report.\n                      FDA database.\n                      Washington, DC: FDA."},{"key":"atypb44","unstructured":"FDA. 2003b. Inactive Ingredients Guide (Redacted), January 1996. http:\/\/www.fda.gov\/cder\/drug\/iig\/default.htm [accessed August 2003]."},{"key":"atypb45","first-page":"538","volume":"227","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb46","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(87)90263-3"},{"key":"atypb47","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(00)00104-4"},{"key":"atypb48","first-page":"268","volume":"4","year":"1997","journal-title":"Environ Dermatol"},{"key":"atypb49","first-page":"321","volume":"40","year":"1989","journal-title":"J Soc Cosmet Chem"},{"key":"atypb50","first-page":"344","volume":"17","year":"1976","journal-title":"Cutis"},{"key":"atypb51","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(78)90659-8"},{"key":"atypb52","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32280-2"},{"key":"atypb53","first-page":"259","volume":"201","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb54","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90347-5"},{"key":"atypb55","first-page":"147","volume":"34","year":"1999","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"atypb56","first-page":"77","volume":"6","year":"2000","journal-title":"Altern Ther Health Med."},{"key":"atypb57","unstructured":"Gennaro, A. R., ed. 1990.Remington's Pharmaceutical Sciences, 18th ed., 785. Easton, PA: Mack Publishing."},{"key":"atypb58","first-page":"2345","volume":"143","year":"1981","journal-title":"Ugeskr Laeger"},{"key":"atypb59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1983.tb01600.x"},{"key":"atypb60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1999.tb06074.x"},{"key":"atypb61","volume-title":"International Cosmetic Ingredient Dictionary and Handbook","year":"2004"},{"key":"atypb62","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80022-X"},{"key":"atypb63","unstructured":"Grant J, ed. 1972.Hackh's Chemical Dictionary, 4th ed., 584. New York: McGraw-Hill Book Co."},{"key":"atypb64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-2494.1979.tb00199.x"},{"key":"atypb65","doi-asserted-by":"publisher","DOI":"10.1042\/bst0171141"},{"key":"atypb66","first-page":"269","volume":"14","year":"1987","journal-title":"Akita J Med"},{"key":"atypb67","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(86)90209-3"},{"key":"atypb68","first-page":"115","volume":"32","year":"1990","journal-title":"Skin Res."},{"key":"atypb69","doi-asserted-by":"publisher","DOI":"10.1002\/em.2860050703"},{"key":"atypb70","first-page":"144","volume":"7","year":"2000","journal-title":"Environ Dermatol"},{"key":"atypb71","unstructured":"Hui, Y. H., ed. 1996.Bailey's Industrial Oil & Fat Products. Industrial and Consumer Nonedible Products from Oils and Fats, 5th ed., vol. 5. 368. New York: John Wiley & Sons."},{"key":"atypb72","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.63.595"},{"key":"atypb73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05818.x"},{"key":"atypb74","unstructured":"International Bio-Research, Inc. 1977a. Delayed contact sensitization (guinea pigs). Compound: \u201cGrillocin HY 77\u201d (undiluted) (Translation). Unpublished data submitted by CTFA. 18 pages."},{"key":"atypb75","unstructured":"International Bio-Research, Inc. 1977b. Patch test for primary skin irritation and corrosivity of the compound: \u201cGrillocin HY 77\u201d (10% soy bean oil). Unpublished data submitted by CTFA. 7 pages."},{"key":"atypb76","first-page":"538","volume-title":"Aerosol Measurement. Principles, Techniques and Applications","year":"1993"},{"key":"atypb77","unstructured":"Johnsen, M. A. 2004. The influence of particle size.\n                      Spray Technology and"},{"key":"atypb78","doi-asserted-by":"publisher","DOI":"10.1177\/030098589303000305"},{"key":"atypb79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1989.tb03201.x"},{"key":"atypb80","first-page":"487","volume":"19","year":"1959","journal-title":"AMA Arch Ind Health"},{"key":"atypb81","first-page":"1260","volume":"39","year":"1970","journal-title":"Chem Ind"},{"key":"atypb82","unstructured":"KIC Chemicals, Inc. 2004. Hydrogenated castor oil, standard grade. Specifications. http:\/\/www.kicchem.com\/hcostandard.htm [accessed September 2004]."},{"key":"atypb83","unstructured":"Laboratoire De Recherche Et D'Experimentation. 1994. Acute oral toxicity and skin irritation and\/or corrosion tests on cetyl ricinoleate. Unpublished data submitted by CTFA, April 13, 2004. 2 pages."},{"key":"atypb84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00586867","volume":"302","year":"1968","journal-title":"Pflugers Arch"},{"key":"atypb85","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00860-2"},{"key":"atypb86","first-page":"114","volume":"42","year":"2000","journal-title":"Contact Dermatitis"},{"key":"atypb87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1980.tb02077.x"},{"key":"atypb88","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2003.0120i.x"},{"key":"atypb89","unstructured":"Lewis, R. J. Sr. 1997.Hawley's Condensed Chemical Dictionary, 13th ed., 221, 749, 922, 972, 1027, 1200. New York: John Wiley & Sons."},{"key":"atypb90","unstructured":"Lewis, R. J., Sr., ed. 2000.Sax's Dangerous Properties of Industrial Materials, 10th ed., 738. New York: John Wiley & Sons."},{"key":"atypb91","unstructured":"Lide, D. R., and H. P. R. Frederiske, eds. 1993.CRC Handbook of Chemistry and Physics, 74th ed., 3\u2013453. Boca Raton, FL: CRC Press."},{"key":"atypb92","first-page":"107","volume":"39","year":"1988","journal-title":"J Soc Cosmet Chem"},{"key":"atypb93","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2000.043006322.x"},{"key":"atypb94","first-page":"49","volume":"57","year":"1994","journal-title":"Eksp Klin Farmakol"},{"key":"atypb95","first-page":"730","volume":"271","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1992.tb00244.x"},{"key":"atypb97","doi-asserted-by":"publisher","DOI":"10.1007\/BF01965109"},{"key":"atypb98","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2001.44020919.x"},{"key":"atypb99","doi-asserted-by":"publisher","DOI":"10.1007\/s004020050013"},{"key":"atypb100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb00850.x"},{"key":"atypb101","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600511022"},{"key":"atypb102","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108975"},{"key":"atypb103","doi-asserted-by":"publisher","DOI":"10.1042\/bst0280972"},{"key":"atypb104","first-page":"986","volume":"162","year":"1976","journal-title":"Dermatol Monatsschr"},{"key":"atypb105","doi-asserted-by":"publisher","DOI":"10.3109\/01485017908987338"},{"key":"atypb106","first-page":"431","year":"1987","journal-title":"SAMJ"},{"key":"atypb107","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600711230"},{"key":"atypb108","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90638-4"},{"key":"atypb109","doi-asserted-by":"publisher","DOI":"10.1007\/BF02660245"},{"key":"atypb110","first-page":"215","volume":"34","year":"1983","journal-title":"J Soc Cosmet Chem"},{"key":"atypb111","first-page":"41","volume":"94","year":"1979","journal-title":"Cosmet Toilet"},{"key":"atypb112","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(92)90042-4"},{"key":"atypb113","unstructured":"National Academy of Sciences (NAS). 1996.\n                      Food Chemicals Codex\n                      , 4th ed., 94 Washington, DC: National Academy Press."},{"key":"atypb114","unstructured":"National Toxicology Program (NTP). 1992. NTP technical report on the toxicity studies of castor oil (CAS No. 8001-79-4) in F344\/N rats and B6C3F1 mice (dosed feed studies). NTIS Report No. PB93151439."},{"key":"atypb115","unstructured":"NTP. 2003.\n                      NTP Chemical Repository.\n                      Castor Oil. Research Triangle Park, NC: NTP."},{"key":"atypb116","volume-title":"CTFA Compendium of Cosmetic Ingredient Composition-Descriptions I and II.","year":"1990"},{"key":"atypb117","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1992.8.295"},{"key":"atypb118","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.jbchem.a127845","volume":"55","year":"1964","journal-title":"J Biochem"},{"key":"atypb119","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8741(91)90031-8"},{"key":"atypb120","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod65.3.913"},{"key":"atypb121","doi-asserted-by":"publisher","DOI":"10.1159\/000228201"},{"key":"atypb122","first-page":"247","volume":"1","year":"1942","journal-title":"Arch Biochem"},{"key":"atypb123","first-page":"313","volume":"23","year":"1972","journal-title":"J Soc Cosmet Chem"},{"key":"atypb124","unstructured":"Physical & Theoretical Chemistry Lab. 2004. Safety (MSDS) data for hy-drogenated castor oil. http:\/\/ptcl.chem.ox.ac.uk\/MSDS\/HY\/hydrogenated castor oil.html [accessed September 2004]."},{"key":"atypb125","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11897.x"},{"key":"atypb126","doi-asserted-by":"publisher","DOI":"10.1007\/BF00997262"},{"key":"atypb127","doi-asserted-by":"publisher","DOI":"10.1042\/bj1620001"},{"key":"atypb128","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(86)80105-6"},{"key":"atypb129","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(00)85641-1"},{"key":"atypb130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1981.tb03986.x"},{"key":"atypb131","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-131-34109"},{"key":"atypb132","first-page":"236","volume":"10","year":"1929","journal-title":"Am J Hyg"},{"key":"atypb133","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2001.045002116.x"},{"key":"atypb134","unstructured":"Research Institute for Fragrance Materials (RIFM). 2000. Fragrance raw materials monographs. Ethyl ricinoleate.\n                      FCT\n                      38:S91-S92."},{"key":"atypb135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1983.tb04631.x"},{"key":"atypb136","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(74)90222-X"},{"key":"atypb137","unstructured":"Sasol North America, Inc. No date. UV spectrum for castor oil and glyceryl ricinoleate. Unpublished data submitted by CTFA, April 14, 2004. 1 page."},{"key":"atypb138","doi-asserted-by":"publisher","DOI":"10.1016\/0378-8741(82)90038-1"},{"key":"atypb139","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)77061-8"},{"key":"atypb140","first-page":"13","volume":"10","year":"1950","journal-title":"Cancer Res"},{"key":"atypb141","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb00025.x"},{"key":"atypb142","unstructured":"Smolinske, S. C.1992.Handbook of Food, Drug, and Cosmetic Excipients, 70. Boca Raton, FL: CRC Press."},{"key":"atypb143","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(00)00572-X"},{"key":"atypb144","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)81268-1"},{"key":"atypb145","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198806000-00016"},{"key":"atypb146","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(76)80148-5"},{"key":"atypb147","first-page":"347","volume":"195","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb148","first-page":"7","volume":"8","year":"1945","journal-title":"Arch Biochem"},{"key":"atypb149","doi-asserted-by":"publisher","DOI":"10.1002\/pca.724"},{"key":"atypb150","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1993.tb04546.x"},{"key":"atypb151","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1997.tb00380.x"},{"key":"atypb152","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198019010-00004"},{"key":"atypb153","unstructured":"TNO BIBRA International Ltd. 1999. Toxicity profile. Castor oil. Surrey, United Kingdom: TNO BIBRA International Ltd. 9 pages."},{"key":"atypb154","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3002(63)90760-1"},{"key":"atypb155","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)43684-8"},{"key":"atypb156","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00727-5"},{"key":"atypb157","doi-asserted-by":"publisher","DOI":"10.1007\/s002100100427"},{"key":"atypb158","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1996.tb02379.x"},{"key":"atypb159","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(62)90078-3"},{"key":"atypb160","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1963.tb12768.x"},{"key":"atypb161","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-89-21817"},{"key":"atypb162","doi-asserted-by":"publisher","DOI":"10.1007\/BF02640467"},{"key":"atypb163","unstructured":"World Health Organization (WHO). 1980. Evaluation of certain food additives. Twenty-third report of the Joint FAO\/WHO Expert Committee on Food Additives, 1-45. World Health Organization Technical Report Series 648. Geneva: WHO."},{"key":"atypb164","first-page":"560","volume":"17","year":"1992","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"atypb165","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(95)90029-2"},{"key":"atypb166","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(75)95563-9"},{"issue":"2","key":"atypb167","first-page":"263","volume":"28","year":"1986","journal-title":"Skin Res"},{"issue":"12","key":"atypb168","first-page":"1","volume":"11","year":"1988","journal-title":"Environ Mol Mutagen"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810701663150","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/10915810701663150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:22:39Z","timestamp":1777458159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/10915810701663150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":168,"journal-issue":{"issue":"3_suppl","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1080\/10915810701663150"],"URL":"https:\/\/doi.org\/10.1080\/10915810701663150","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}